Pfizer Inc
Investment Portfolio & 13F Holdings Analysis
About
PFIZER INC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 21 holdings worth $0.5 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.
AI_NATIVE detailed information: This accession holds the following tickers:[ "ORIC", "ANTX", "SENS", "DNA", "CRBU", "ARVN", "ALLO", "TRML", "BOLT", "EPIX", "NXTC", "PYXS", "QTTB", "SPRO", "ZURA", "WVE", "ZNTL", "BHVN", "BNTX", "CRDF", "CELC" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-13
- Total Holdings
- 21
- Total Value
- 494849864
- Accession Number
- 0000078003-25-000118
- Form Type
- 13F-HR
- CIK
- pfizer
- Manager Name
- Pfizer
Data Enrichment
100% identified21 identified0 unidentified
Holdings
21 positions • $494.8M total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
Shares:22.0M
Value:$32.2M
% of Portfolio:6.5% ($32.2M/$494.8M)
Shares:953.8K
Value:$1.5M
% of Portfolio:0.3% ($1.5M/$494.8M)
Shares:626.1K
Value:$250.4K
% of Portfolio:0.1% ($250.4K/$494.8M)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
---|---|---|---|---|---|---|
BioNTech SE(BNTXcusip09075V102) | 3.7M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $333.1M | 67.3% ($333.1M/$494.8M) | YoY- |
22.0M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $32.2M | 6.5% ($32.2M/$494.8M) | YoY- | |
5.4M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $30.0M | 6.1% ($30.0M/$494.8M) | YoY- | |
ARVINAS, INC.(ARVNcusip04335A105) | 3.5M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $24.3M | 4.9% ($24.3M/$494.8M) | YoY- |
1.3M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $19.4M | 3.9% ($19.4M/$494.8M) | YoY- | |
1.9M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $15.2M | 3.1% ($15.2M/$494.8M) | YoY- | |
Biohaven Ltd.(BHVNcusipG1110E107) | 505.6K | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $12.2M | 2.5% ($12.2M/$494.8M) | YoY- |
2.4M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $7.6M | 1.5% ($7.6M/$494.8M) | YoY- | |
4.7M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $4.3M | 0.9% ($4.3M/$494.8M) | YoY- | |
Zura Bio Ltd(ZURAcusipG9TY5A101) | 3.0M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $3.8M | 0.8% ($3.8M/$494.8M) | YoY- |
Celcuity Inc.(CELCcusip15102K100) | 349.4K | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $3.5M | 0.7% ($3.5M/$494.8M) | YoY- |
1.7M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $2.6M | 0.5% ($2.6M/$494.8M) | YoY- | |
2.4M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $1.7M | 0.3% ($1.7M/$494.8M) | YoY- | |
953.8K | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $1.5M | 0.3% ($1.5M/$494.8M) | YoY- | |
1.1M | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $1.1M | 0.2% ($1.1M/$494.8M) | YoY- | |
715.3K | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $972.8K | 0.2% ($972.8K/$494.8M) | YoY- | |
NextCure, Inc.(NXTCcusip65343E108) | 1.6M | YoY- | All Managers (Combined) | $755.7K | 0.2% ($755.7K/$494.8M) | YoY- |
Q32 Bio Inc.(QTTBcusip746964105) | 277.8K | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $458.3K | 0.1% ($458.3K/$494.8M) | YoY- |
626.1K | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $250.4K | 0.1% ($250.4K/$494.8M) | YoY- | |
43.4K | QoQ 0.00% (+0)YoY- | All Managers (Combined) | $28.5K | 0.0% ($28.5K/$494.8M) | YoY- |